Evidence map›Paper›PMID 24972088›Full record

ArticleDevelopmental biology2014

Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development.

Laura Mangiavini, Christophe Merceron, Elisa Araldi, Richa Khatri, Rita Gerard-O'Riley, Tremika LeShan Wilson, Erinn B Rankin, Amato J Giaccia, Ernestina Schipani

Open access · greenAbstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Deletion ofFrontiers in immunology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Analysis of Mouse Growth Plate Development.Current protocols in mouse biology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Laura MangiaviniDepartment of Orthopaedic Surgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Division of Endocrinology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Department of Orthopaedic and Traumatology, Milano-Bicocca University, 20900 Monza (MB), Italy.
Christophe MerceronDepartment of Orthopaedic Surgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Division of Endocrinology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA; Inserm, UMRS 791-LIOAD, Centre for Osteoarticular and Dental Tissue Engineering, Group STEP 'Skeletal Tissue Engineering and Physiopathology', 44042 Nantes, France; LUNAM, Nantes University, Faculty of Dental Surgery, Nantes, France.
Elisa AraldiEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Richa KhatriEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Rita Gerard-O'RileyDivision of Endocrinology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
Tremika LeShan WilsonDepartment of Orthopaedic Surgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Division of Endocrinology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Erinn B RankinEndocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA 94303-5152, USA.
Amato J GiacciaDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA 94303-5152, USA.
Ernestina SchipaniDepartment of Orthopaedic Surgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA; Division of Endocrinology, Department of Medicine, School of Medicine, Indiana University, Indianapolis, IN 46202, USA; Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA; Division of Endocrinology, Department of Medicine, Medical School, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: eschipan@med.umich.edu.
Harvard University · USIndiana University Indianapolis · USInserm · FRStanford University · US

Funding

HIF-1alpha, a Survival and Differentiation Factor for CartilageR01AR065403 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHIPANI, ERNESTINA · 2013 to 2017
$1.7M
NIAMS NIH HHS R01 AR065403NIAMS NIH HHS R01AR065403-01
6 · The paper itself

Abstract

Adaptation to low oxygen tension (hypoxia) is a critical event during development. The transcription factors Hypoxia Inducible Factor-1α (HIF-1α) and HIF-2α are essential mediators of the homeostatic responses that allow hypoxic cells to survive and differentiate. Von Hippel-Lindau protein (VHL) is the E3 ubiquitin ligase that targets HIFs to the proteasome for degradation in normoxia. We have previously demonstrated that the transcription factor HIF-1α is essential for survival and differentiation of growth plate chondrocytes, whereas HIF-2α is not necessary for fetal growth plate development. We have also shown that VHL is important for endochondral bone development, since loss of VHL in chondrocytes causes severe dwarfism. In this study, in order to expand our understanding of the role of VHL in chondrogenesis, we conditionally deleted VHL in mesenchymal progenitors of the limb bud, i.e. in cells not yet committed to the chondrocyte lineage. Deficiency of VHL in limb bud mesenchyme does not alter the timely differentiation of mesenchymal cells into chondrocytes. However, it causes structural collapse of the cartilaginous growth plate as a result of impaired proliferation, delayed terminal differentiation, and ectopic death of chondrocytes. This phenotype is associated to delayed replacement of cartilage by bone. Notably, loss of HIF-2α fully rescues the late formation of the bone marrow cavity in VHL mutant mice, though it does not affect any other detectable abnormality of the VHL mutant growth plates. Our findings demonstrate that VHL regulates bone morphogenesis as its loss considerably alters size, shape and overall development of the skeletal elements.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell HypoxiaCell ProliferationCells, CulturedChondrogenesisEndothelial PAS Domain-Containing Protein 1Growth PlateHypoxia-Inducible Factor 1, alpha SubunitLimb BudsMesenchymal Stem CellsMiceMice, Inbred C57BLMice, TransgenicOsteogenesisBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitVHL protein, mouseVon Hippel-Lindau Tumor Suppressor ProteinEndochondral bone developmentHypoxia Inducible FactorLimb bud mesenchymeVon Hippel–Lindau

Identifiers

PMID24972088
PMCPMC4335807
OpenAlexW2000239462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.